Back

What risk factors influence vitamin K antagonists overdose?

4 March 2018 (14:00 - 17:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Acute Coronary Syndromes (Other) - General Acute Coronary Sydrome Thrombosis, Platelets, and Coagulation ACVC Premium Access Acute Cardiovascular Care 2018

About the speaker

Photo
Doctor Mindaugas Lizaitis

Republican Vilnius University Hospital, Vilnius (Lithuania)

34 More presentations in this session

Presentation thumbnail
Professor B. Safdar (New Haven, US)
Abstract Slides
Presentation thumbnail
Doctor K. Naeem (Dubai, AE)
Abstract Slides
Presentation thumbnail
Doctor A. Conti (Massa, IT)
Presentation thumbnail
Assistant Professor O. Germanova (Bishkek, KG)
Abstract Slides
Presentation thumbnail
Associate Professor D. Shorikova (Chernivtsi, UA)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Acute Coronary Syndromes (Other) - General Acute Coronary Sydrome

The Event

Event poster

Acute Cardiovascular Care 2018

4 March 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in (morbidly) obese or low body weight patients with atrial fibrillation: a meta-analysis
23 April 2021
thumbnail
Congress Presentation
Association of vitamin D deficiency and cardiovascular risk factors
20 May 2023
thumbnail
Congress Presentation
Global risk factors of contrast-Induced acute kidney injury: systematic review and meta-analysis
28 August 2020
thumbnail
Congress Presentation
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources